Cartesian Therapeutics
RNAC
#8958
Rank
โ‚ฌ0.17 B
Marketcap
5,60ย โ‚ฌ
Share price
4.24%
Change (1 day)
-10.96%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2026 (TTM): -โ‚ฌ44.96 Million

According to Cartesian Therapeutics's latest financial reports the company's current earnings are โ‚ฌ1.47 Million. In 2025 the company made an earning of -โ‚ฌ44.68 Million a decrease over its 2024 earnings that were of -โ‚ฌ24.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ44.96 Million0.63%
2025 -โ‚ฌ44.68 Million80.63%
2024 -โ‚ฌ24.74 Million-88.5%
2023 -โ‚ฌ0.22 Billion-724%
2022 โ‚ฌ34.45 M-649.67%
2021 -โ‚ฌ6.27 Million-89.78%
2020 -โ‚ฌ61.37 Million25.06%
2019 -โ‚ฌ49.08 Million-15.68%
2018 -โ‚ฌ58.2 Million-0.43%
2017 -โ‚ฌ58.45 Million83.41%
2016 -โ‚ฌ31.87 Million44.3%
2015 -โ‚ฌ22.09 Million